Interestingly, the high expression of CXCL14, a powerful angiostatic chemokine that inhibits angiogenesis, is correlated with good progression-free survival in endometrioid ovarian cancer and is expressed in normal tissues such as epithelia and ovarian cancer stroma [67, 69, 70, 73]. The gene discussed is CXCL14; the disease is ovarian endometrioid adenocarcinoma.